Jonathan Davis, of Port Washington, will peddle from New York to Portland — nearly 4,300 miles — over two months to raise ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

Significant advances have been made in the understanding of the genetics of retinitis pigmentosa (RP), a clinically and genetically heterogeneous group of disorders; and over 50 genes underlying ...

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design ...

Attendance Allowance could help people who are severely short-sighted or have eye conditions including cataract, glaucoma or ...

Discover surprising truths about blindness, from the spectrum of visual impairment to revolutionary treatments and adaptive ...

Cataracts are an incredibly common condition that creates a cloudy area on the lens of the eye. As a result, your vision may be blurry or unclear, and colors may seem less bright or hazy and faded.

That's very encouraging for future applications." The approach has similarities to existing treatments for AMD and related conditions such as retinitis pigmentosa. However, this new method is less ...